The article details the growing concerns among Australian exporters as the U.S.government prepares to implement new tariffs on 60 countries, including Australia.These tariffs, proposed at 12.5%, are intended to penalize nations allowing imports from forced labor.Australian companies, such as Cochlear and Bubs Australia, are lobbying to exempt products like cochlear implants and baby formula from the tariffs.

The Australian government argues its modern slavery protections are robust and that the tariffs would disrupt supply chains and harm vulnerable populations, including children reliant on Medicaid-funded implants.The U.S.trade office accused Australia of failing to enforce forced labor bans, but Australia's submission highlights its legal framework and the U.S.State Department's recognition of Australia's anti-trafficking efforts.The article also notes the potential economic impact on U.S.manufacturers and consumers, with warnings that tariffs could reduce access to critical medical devices and strain healthcare funding.The White House remains silent on the specifics, while other tariffs on Canadian and Brazilian goods are already in place.